The involvement of anti-apoptotic Bcl-2 family proteins in vinblastine-induced apoptosis

2009 2009

Other formats: Order a copy

Abstract (summary)

The efficacy of many chemotherapeutic agents can be attenuated by expression of the anti-apoptotic proteins Bcl-2, Bcl-X and Mcl-1. When ML-1 leukemia cells are incubated with vinblastine, they rapidly upregulate Mcl-1. Suppression of Mcl-1 with inhibitors of MEK-ERK signaling or by expression of shRNA dramatically accelerates the rate of apoptosis with cells dying in 4 hours. However, most leukemia cells appear to rely on Bcl-2 or Bcl-X rather than Mcl-1 to protect themselves from this acute vinblastine-mediated apoptosis. Small molecule inhibitors of Bcl-2 proteins were investigated for their ability to sensitize a range of leukemia cell lines to vinblastine. ABT-737, an inhibitor of Bcl-2 and Bcl-X, acutely sensitized only the NB4 cells which express only Bcl-2. Most of the other cell lines also expressed Mcl-1 which may provide resistance to ABT-737. However, GX15-070, which inhibits Mcl-1, Bcl-2 and Bcl-X only sensitized the ML-1 cells. This was attributed to its ability to inhibit MEK-ERK signaling and consequently suppress Mcl-1 protein levels. This is an off-target effect of this inhibitor, and no on-target effect was confirmed. As an alternative means to suppress Mcl-1, global transcription was suppressed with flavopiridol. Flavopiridol acutely sensitized most of the leukemia lines to vinblastine. Because flavopiridol-mediated sensitization did not correlate with expression of Mcl-1, these results suggest another short-lived protein suppresses this acute apoptosis. It is proposed that vinblastine primes the cells for apoptosis by activating a pro-apoptotic Bcl-2 protein while concurrent inhibition of anti-apoptotic proteins leads to rapid apoptosis. The rapid apoptosis is dependent on vinblastine-mediated activation of JNK which may cause concurrent inhibition of Bcl-2. One exception is the sensitization of NB4 cells to ABT-737, a situation where JNK-mediated inhibition of Bcl-2 would be redundant. Interestingly, OCI-AML1 cells were acutely sensitive to vinblastine alone, which was attributed to their expression of only Bcl-2 and at very low levels. The results have clinical significance as they show that brief administration of these drugs in combination can be sufficient to kill leukemia cells. A future challenge will be to determine which tumors will respond to each drug combination.

Indexing (details)

Molecular biology
0307: Molecular biology
Identifier / keyword
Biological sciences; Apoptosis; Bcl-2; Leukemia; Mcl-1
The involvement of anti-apoptotic Bcl-2 family proteins in vinblastine-induced apoptosis
Salerni, Bethany L.
Number of pages
Publication year
Degree date
School code
DAI-B 71/04, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
Eastman, Alan R.
Committee member
Cole, Michael; Lowrey, Christopher; Noelle, Randolph
Dartmouth College
Pharmacology and Toxicology
University location
United States -- New Hampshire
Source type
Dissertations & Theses
Document type
Dissertation/thesis number
ProQuest document ID
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.